| Literature DB >> 29749647 |
Luisa Zupin1, Ilaria Caracciolo1, Paola Maura Tricarico1, Giulia Ottaviani1, Pierlanfranco D'Agaro1, Sergio Crovella1,2.
Abstract
Herpes simplex virus type-1 (HSV-1) is known to cause lifelong infections in humans. First infection is characterized by gingiva-stomatitis and pharyngitis, while virus reactivation causes recurrent herpes labialis with ulcerations on intraoral mucosa, mouth or external facial skin [1]. Laser therapy (LT), set at red and infrared wavelengths, has been reported as able to reduce HSV-1 recurrence and duration of herpetic sores [2]. Despite the blue wavelength already showed its efficacy in killing different strains of bacteria, it has never been tested on viruses [3].Entities:
Keywords: HSV-1; blue laser therapy; infection
Year: 2018 PMID: 29749647 DOI: 10.1111/1348-0421.12600
Source DB: PubMed Journal: Microbiol Immunol ISSN: 0385-5600 Impact factor: 1.955